ZNF600
gene geneOn this page
Also known as KR-ZNF1DKFZp686F06123
Summary
ZNF600 (zinc finger protein 600, HGNC:30951) is a protein-coding gene on chromosome 19q13.42, encoding Zinc finger protein 600 (Q6ZNG1). May be involved in transcriptional regulation.
Predicted to enable DNA binding activity and zinc ion binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 162966 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 157 total
- MANE Select transcript:
NM_001321866
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30951 |
| Approved symbol | ZNF600 |
| Name | zinc finger protein 600 |
| Location | 19q13.42 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KR-ZNF1, DKFZp686F06123 |
| Ensembl gene | ENSG00000189190 |
| Ensembl biotype | protein_coding |
| Entrez | 162966 |
Gene structure
Transcript identifiers
Ensembl transcripts: 24 — 20 protein_coding, 2 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay
ENST00000338230, ENST00000598369, ENST00000599893, ENST00000647907, ENST00000648893, ENST00000648973, ENST00000685388, ENST00000688329, ENST00000692063, ENST00000880463, ENST00000880464, ENST00000880465, ENST00000880466, ENST00000880467, ENST00000880468, ENST00000880469, ENST00000880470, ENST00000929806, ENST00000929807, ENST00000929808, ENST00000941328, ENST00000941329, ENST00000941330, ENST00000941331
RefSeq mRNA: 3 — MANE Select: NM_001321866
NM_001321866, NM_001321867, NM_198457
CCDS: CCDS12856, CCDS92675
Canonical transcript exons
ENST00000692063 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002999669 | 52781317 | 52781464 |
| ENSE00003032870 | 52780581 | 52781055 |
| ENSE00003050514 | 52786595 | 52786791 |
| ENSE00003839668 | 52774575 | 52774701 |
| ENSE00003841018 | 52778826 | 52778907 |
| ENSE00003937606 | 52764184 | 52767772 |
Expression profiles
Bgee: expression breadth ubiquitous, 249 present calls, max score 93.83.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.1463 / max 128.8451, expressed in 1454 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 182533 | 4.9665 | 1436 |
| 182534 | 0.1799 | 64 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pancreatic ductal cell | CL:0002079 | 93.83 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 93.21 | gold quality |
| granulocyte | CL:0000094 | 92.46 | gold quality |
| ileal mucosa | UBERON:0000331 | 89.65 | gold quality |
| oocyte | CL:0000023 | 89.22 | gold quality |
| secondary oocyte | CL:0000655 | 89.12 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 87.39 | gold quality |
| cerebellar cortex | UBERON:0002129 | 87.29 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 87.29 | gold quality |
| visceral pleura | UBERON:0002401 | 86.96 | gold quality |
| jejunal mucosa | UBERON:0000399 | 86.87 | gold quality |
| parietal pleura | UBERON:0002400 | 86.74 | gold quality |
| cerebellum | UBERON:0002037 | 86.70 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 86.59 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 86.53 | gold quality |
| amniotic fluid | UBERON:0000173 | 86.29 | gold quality |
| colonic mucosa | UBERON:0000317 | 86.08 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 86.08 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 85.41 | gold quality |
| placenta | UBERON:0001987 | 84.41 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 84.26 | gold quality |
| upper leg skin | UBERON:0004262 | 84.01 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.78 | gold quality |
| small intestine | UBERON:0002108 | 83.34 | gold quality |
| right uterine tube | UBERON:0001302 | 83.12 | gold quality |
| upper arm skin | UBERON:0004263 | 83.03 | gold quality |
| skin of hip | UBERON:0001554 | 82.81 | gold quality |
| rectum | UBERON:0001052 | 82.76 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 82.69 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 82.68 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.22 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
59 targeting ZNF600, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-574-5P | 100.00 | 66.01 | 989 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-2052 | 99.79 | 69.37 | 2031 |
| HSA-MIR-3680-3P | 99.75 | 72.51 | 3095 |
| HSA-MIR-548AV-5P | 99.60 | 70.84 | 2107 |
| HSA-MIR-548K | 99.60 | 70.84 | 2107 |
| HSA-MIR-106A-3P | 99.53 | 67.58 | 995 |
| HSA-MIR-6832-3P | 99.52 | 70.44 | 1726 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-8054 | 99.48 | 70.81 | 2084 |
| HSA-MIR-142-5P | 99.48 | 70.92 | 2416 |
| HSA-MIR-5590-3P | 99.48 | 70.91 | 2429 |
| HSA-MIR-19A-5P | 99.36 | 66.93 | 1675 |
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 600 — Q6ZNG1 (reviewed: Q6ZNG1)
All UniProt accessions (4): A0A3B3IT03, A0A3B3ITH4, A0A3B3ITY9, Q6ZNG1
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (3): NP_001308795, NP_001308796, NP_940859 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF12874
UniProt features (26 total): zinc finger region 20, sequence variant 3, sequence conflict 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZNG1-F1 | 68.20 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 91 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN, RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, PEREZ_TP63_TARGETS, PEREZ_TP53_AND_TP63_TARGETS, NOUZOVA_TRETINOIN_AND_H4_ACETYLATION, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, ARNT2_TARGET_GENES, HMG20B_TARGET_GENES, PAX7_TARGET_GENES, ZNF768_TARGET_GENES, MIR616_5P, MIR371B_5P, MIR373_5P
GO Biological Process (4): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355), regulation of gene expression (GO:0010468), negative regulation of macromolecule biosynthetic process (GO:0010558)
GO Molecular Function (4): DNA binding (GO:0003677), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of macromolecule biosynthetic process | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| gene expression | 1 |
| macromolecule biosynthetic process | 1 |
| negative regulation of biosynthetic process | 1 |
| negative regulation of macromolecule metabolic process | 1 |
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
380 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF600 | NBPF26 | B4DH59 | 507 |
| ZNF600 | A6NLF2 | A6NLF2 | 506 |
| ZNF600 | A0A087WTG0 | A0A087WTG0 | 506 |
| ZNF600 | TTC33 | Q6PID6 | 378 |
| ZNF600 | TMEM217B | A0A494BZU4 | 369 |
| ZNF600 | TMEM217 | Q8N7C4 | 367 |
| ZNF600 | Q8NG57 | Q8NG57 | 335 |
| ZNF600 | VPS13B | Q7Z7G8 | 328 |
| ZNF600 | C9JR48 | C9JR48 | 322 |
| ZNF600 | ACOT6 | Q3I5F7 | 320 |
| ZNF600 | LRRC37A2 | A6NM11 | 317 |
| ZNF600 | ACTL8 | Q9H568 | 312 |
| ZNF600 | PPWD1 | Q96BP3 | 305 |
| ZNF600 | CARF | Q8N187 | 305 |
| ZNF600 | RAD9B | Q6WBX8 | 278 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRTAP10-6 | ZNF600 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF600 | KRTAP10-6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MAPK6 | ZNF600 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (4): ZNF600 (Two-hybrid), ZNF600 (Affinity Capture-MS), ZNF600 (Cross-Linking-MS (XL-MS)), ZNF600 (Two-hybrid)
ESM2 similar proteins: A6NDX5, A6NK75, A6NNF4, A6NP11, B4DXR9, B7Z6K7, C9JN71, O43361, O75290, O75373, P0CJ79, P0DKX0, P17019, P17021, P17035, P17039, P35789, Q02386, Q03938, Q08AN1, Q13106, Q15928, Q3ZCX4, Q5R9F0, Q5SXM1, Q68EA5, Q6P9A1, Q6PDB4, Q6ZN06, Q6ZN08, Q6ZNG1, Q76KX8, Q86V71, Q86XN6, Q8IYB9, Q8N4W9, Q8NEP9, Q8TBZ8, Q8TC21, Q8TF32
Diamond homologs: A0A1W2PQL4, A2RRD8, A2VDQ7, A6NHJ4, A6NK75, A6NN14, A6NNF4, A6NP11, B4DX44, B4DXR9, E9PW05, O14628, O43345, O75290, O75346, O75373, O75820, P0CB33, P0CJ79, P0DKX0, P10755, P17032, P17035, P52738, Q02386, Q03923, Q03936, Q05481, Q08AN1, Q09FC8, Q0VGE8, Q14586, Q14593, Q147U1, Q15928, Q3MIS6, Q3SXZ3, Q494X3, Q4R6C2, Q5HY98
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
157 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 128 |
| Likely benign | 13 |
| Benign | 10 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
768 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:52778914:G:C | acceptor_gain | 1.0000 |
| 19:52767770:TAT:T | acceptor_gain | 0.9900 |
| 19:52774614:C:A | donor_gain | 0.9900 |
| 19:52778816:A:AC | donor_gain | 0.9900 |
| 19:52778853:T:A | donor_gain | 0.9900 |
| 19:52778903:CAATC:C | acceptor_gain | 0.9900 |
| 19:52778906:TC:T | acceptor_gain | 0.9900 |
| 19:52778906:TCC:T | acceptor_loss | 0.9900 |
| 19:52778907:CC:C | acceptor_gain | 0.9900 |
| 19:52778908:C:CA | acceptor_loss | 0.9900 |
| 19:52778908:C:CC | acceptor_gain | 0.9900 |
| 19:52778912:A:C | acceptor_gain | 0.9900 |
| 19:52778914:G:GC | acceptor_gain | 0.9900 |
| 19:52786582:T:TA | donor_gain | 0.9900 |
| 19:52786589:TCTTA:T | donor_loss | 0.9900 |
| 19:52786590:CTTA:C | donor_loss | 0.9900 |
| 19:52786591:TTA:T | donor_loss | 0.9900 |
| 19:52786592:TACC:T | donor_loss | 0.9900 |
| 19:52786593:A:AC | donor_gain | 0.9900 |
| 19:52786593:A:AG | donor_loss | 0.9900 |
| 19:52786594:C:CC | donor_gain | 0.9900 |
| 19:52767768:GATAT:G | acceptor_gain | 0.9800 |
| 19:52767772:TC:T | acceptor_loss | 0.9800 |
| 19:52767773:C:CA | acceptor_loss | 0.9800 |
| 19:52767773:C:CC | acceptor_gain | 0.9800 |
| 19:52767774:T:C | acceptor_loss | 0.9800 |
| 19:52778820:CTTCA:C | donor_loss | 0.9800 |
| 19:52778822:T:TA | donor_gain | 0.9800 |
| 19:52778822:TCA:T | donor_loss | 0.9800 |
| 19:52778823:CAC:C | donor_loss | 0.9800 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000023557 (19:52797426 A>C), RS1000077423 (19:52797694 A>C,T), RS1000097013 (19:52798556 T>C), RS1000150928 (19:52798254 C>T), RS1000188220 (19:52774441 C>A,T), RS1000219757 (19:52828246 T>A), RS1000239116 (19:52768404 C>T), RS1000322919 (19:52764699 A>G), RS1000433727 (19:52788856 T>C), RS1000457592 (19:52823011 A>C), RS1000495693 (19:52769558 A>G), RS1000551525 (19:52783179 T>G), RS1000606465 (19:52829039 T>C), RS1000610410 (19:52794789 G>A), RS1000681844 (19:52793974 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001414_11 | Phospholipid levels (plasma) | 9.000000e-09 |
| GCST006479_21 | Diverticular disease | 8.000000e-06 |
| GCST008477_3 | Emphysema annual change measurement in smokers (adjusted lung density) | 6.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009959 | diverticular disease |
| EFO:0007626 | emphysema imaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
31 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression | 6 |
| trichostatin A | affects cotreatment, increases expression | 3 |
| Aflatoxin B1 | affects expression, increases expression, increases methylation | 3 |
| entinostat | affects cotreatment, increases expression | 2 |
| Panobinostat | affects cotreatment, increases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, increases expression | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| bisphenol F | affects cotreatment, decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects cotreatment, decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| butyraldehyde | increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation, increases methylation | 1 |
| Dexamethasone | affects cotreatment, decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Quercetin | increases expression | 1 |
| Smoke | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, decreases expression | 1 |
| 1-Methyl-4-phenylpyridinium | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Lactic Acid | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_HD32 | HEK293 eGFP-ZNF600 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.